Schellenberg Wittmer acted as Swiss legal counsel to Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, in respect of a USD 75 million senior secured credit facility granted to ObsEva SA (NASDAQ: OBSV / SIX: OBSN). ObsEva is a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.